Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neptuno: Plitidepsin in Moderate COVID-19
NCT04784559Phase 3Terminated
- Sponsor
- PharmaMar
- Start
- Jun 2021
- Primary completion
- Mar 2023
- Modality
- Cyclic Peptides, Peptide-Drug Conjugates
- Countries
- 8
01
Overview
A Phase 3 trial of plitidepsin in coronavirus disease 2019 (COVID-19), sponsored by PharmaMar. Started Jun 2021; status: terminated.
02
Drugs
plitidepsin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04784559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04784559.